CorMedix's 15-minute chart triggers KDJ Death Cross, Bearish Marubozu formation.

According to the 15-minute chart for CorMedix, a technical analysis indicator called the KDJ Death Cross has been triggered. This indicator suggests that the momentum of the stock price is shifting towards the downside, and there is potential for further decreases in the stock price. The bearish Marubozu at 07/16/2025 10:00 indicates that sellers are currently in control of the market, and that the bearish momentum is likely to continue.

CorMedix Inc. (CRMD), a pharmaceutical and medical device company, has consistently exceeded earnings estimates in recent quarters. According to Zacks Investment Research [1], CorMedix topped estimates by an average of 24.71% over the last two quarters. For the most recent quarter, the company reported earnings of $0.3 per share, surpassing the Zacks Consensus Estimate of $0.25 per share by 20.00%. The previous quarter also saw CorMedix beat estimates by 29.41%, posting earnings of $0.22 per share against an expected $0.17 per share.

The company's positive Earnings ESP (Expected Surprise Prediction) of +20.00% suggests that analysts have become bullish on CorMedix's earnings prospects. This indicator, when combined with the stock's Zacks Rank #3 (Hold), increases the likelihood of another earnings beat. Zacks Investment Research notes that stocks with this combination have a 70% chance of beating the consensus estimate [1].

However, technical analysis indicates potential headwinds for CorMedix. According to a 15-minute chart, the KDJ Death Cross has been triggered, signaling a shift in momentum towards the downside. Additionally, a bearish Marubozu on July 16, 2025, suggests that sellers are currently in control of the market, potentially leading to further price decreases.

Investors should monitor CorMedix's earnings report closely, as the company's ability to maintain its earnings beat streak remains crucial. The technical indicators, while not definitive, provide additional context for potential price movements.

References:
[1] https://www.nasdaq.com/articles/can-cormedix-crmd-keep-earnings-surprise-streak-alive